Prolaio, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$21Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
5clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2023 $3,375
2024 $8,515
2025 $8,675

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Obstetrics & Gynecology (Nurse Practitioner) $16K
Internal Medicine $1,953
Pulmonary Disease $1,500
Cardiovascular Disease $800

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Maureen Fagan Framingham, MA Obstetrics & Gynecology (Nurse Practitioner) $16,312.50
Vivek Reddy Newark, DE Internal Medicine $1,952.50
William Stringer Torrance, CA Pulmonary Disease $1,500.00
Iani Patsias Hollywood, FL Cardiovascular Disease $800.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.